EFFECTIVE CONTROL, TREATMENT AND PREVENTION OF ANEMIA IN HEART FAILURE AND DISEASES IN THE FERGANA VALLEY

dc.contributor.authorAxunbayev Otabek Adilovich
dc.date.accessioned2025-12-31T07:23:08Z
dc.date.issued2025-12-31
dc.description.abstractThis study examines anemia correction protocols in 284 cardiovascular patients across three clinical centers in the Fergana Valley during 2022-2024. Combined iron supplementation with erythropoiesis-stimulating agents demonstrated hemoglobin elevation from 98.4 g/L to 118.7 g/L over 16 weeks, alongside reduced hospitalization rates by 34% and improved functional capacity in NYHA class II-III patients with concurrent heart failure and iron deficiency anemia.
dc.formatapplication/pdf
dc.identifier.urihttps://webofjournals.com/index.php/5/article/view/5765
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/39715
dc.language.isoeng
dc.publisherWeb of Journals Publishing
dc.relationhttps://webofjournals.com/index.php/5/article/view/5765/5784
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.sourceWeb of Medicine: Journal of Medicine, Practice and Nursing ; Vol. 3 No. 12 (2025): WOM; 441-446
dc.source2938-3765
dc.subjectanemia, heart failure, iron deficiency, cardiovascular diseases, erythropoiesis-stimulating agents, hemoglobin, ferritin, NYHA classification, Fergana Valley, cardiorenal syndrome, hospitalization, quality of life, ferrous sulfate, intravenous iron, treatment outcomes.
dc.titleEFFECTIVE CONTROL, TREATMENT AND PREVENTION OF ANEMIA IN HEART FAILURE AND DISEASES IN THE FERGANA VALLEY
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
adilovich_2025_effective_control_treatment_and_preventi.pdf
item.page.filesection.size
332.77 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections